DBP B — Double Bond Pharmaceutical International AB (publ) Cashflow Statement
0.000.00%
Last trade - 00:00- SEK41.36m
- SEK39.18m
- SEK1.09m
Annual cashflow statement for Double Bond Pharmaceutical International AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -17.7 | -9.26 | -15.2 | -17.3 | -7.11 |
| Depreciation | |||||
| Non-Cash Items | -0.513 | -10 | 0 | 8.53 | 5.42 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.098 | -0.953 | 1.61 | 5.74 | 1.58 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -18 | -20 | -13.4 | -3.08 | -0.114 |
| Capital Expenditures | -0.502 | -0.326 | 0 | — | -6.13 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | 1.67 | 0 | -6.21 | 0.545 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Cash from Investing Activities | -0.502 | 1.34 | 0 | -6.21 | -5.59 |
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 28.6 | 15.9 | 3.34 | 10.6 | 5.76 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 10.1 | -2.83 | -10 | 1.33 | 0.059 |